Access cutting-edge facioscapulohumeral muscular dystrophy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access facioscapulohumeral muscular dystrophy specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related facioscapulohumeral muscular dystrophy treatment provided free
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Sponsor: Avidity Biosciences, Inc.
Check if you qualify for this facioscapulohumeral muscular dystrophy clinical trial in Palo Alto, CA
If you're searching for facioscapulohumeral muscular dystrophy treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced facioscapulohumeral muscular dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.